DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time ... STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and ...

Abbott rolled out its first over-the-counter glucose sensor in the U.S. on Thursday, just over one week after Dexcom began selling its competing product. The device, called Lingo, is intended to be ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

Commercial partner Ascensia is in discussions with insulin pump manufacturers to create an automated insulin delivery system.

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...

Now, Dexcom's Stelo is the first wearable glucose sensor available over the counter to anyone. It's being marketed to people with Type 2 diabetes or prediabetes who are not taking insulin to help them ...

For once, you don’t have to wait a year to get the best new features from the iPhone 16 Pro. The iPhone 16 offers all the ...